CryoLife's next-gen hemodialysis device gains 510(k) clearance

04/5/2013 | RTT News

The FDA has cleared CryoLife to market its Hemodialysis Reliable Outflow, or HeRO, system. The next-generation device, set to be released in the fourth quarter, provides long-term AV access for central venous stenosis patients undergoing hemodialysis and improves on the original version with an adaptor for integration with other dialysis access grafts.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI